RecruitingPhase 3NCT06961214
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Sponsor: GlaxoSmithKline
Shelby, NC · +56 more sites
2 recruiting copd studies with a site in Shelby, NC.
Sponsor: GlaxoSmithKline
Shelby, NC · +56 more sites
Sponsor: Expedition Therapeutics, Inc
Shelby, NC · +21 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.